Hypoglycemic Effects of Crude Extracts of Moutan Radicis Cortex

목단피 추출물의 혈당 강하 효과

  • Published : 2004.06.30

Abstract

Hypoglycemie effect of Moutan Radicis Cortex (MRC) extract contained in Yukmijihuang-hwan was determined by investigating insulin-sensitizing and ${\alpha}-glucoamylase-suppressing$ actions. MRC was extracted with 70% ethanol, fractionated by XAD-4 column chromatography with mixture solvent of methanol and water, and utilized for hypoglycemic effect assay. Significant insulin sensitizing activities of MRC extracts were observed in 3T3-L1 adipocytes, giving MRC extracts with 1 ng/mL insulin reach glucose uptake level increased by 50 ng/mL of insulin alone. MRC methanol extracts of 20, 40, 60, and 80% suppressed ${\alpha}-glucoamylase$ activity in vitro. Peak serum glucose levels and area under curve were lower in Sprague Dawley male rats treated with MRC ethanol extract than those treated with cellulose in oral glucose tolerance test using 2 g dextrin/kg body weight. These data suggest MRC extracts contain effective insulin -sensitizing and ${\alpha}-glucoamylase-suppressing$ compounds for hypoglycemic activity.

Keywords

3T3-L1 adipocytes;insulin sensitizer;${\alpha}-glucoamylase$;Moutan Radicis;dextrin

References

  1. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: A balanced overview. Diabetes Care 15: 318-353 (1992) https://doi.org/10.2337/diacare.15.3.318
  2. Kahn SE, Prigeon RL, McCulloch DK. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663-1672 (1993) https://doi.org/10.2337/diabetes.42.11.1663
  3. Fineman MS, Bicsak TA, Shen LZ, Taylor K, Gaines E, Varns A, Kim D, Baron AD. Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes. Diabetes Care 26: 2370-2377 (2003) https://doi.org/10.2337/diacare.26.8.2370
  4. Goldstein BJ, Pans M, Rubin CJ. Multi-center, randomized, double-masked, parallel-group assessment of simultaneous glipizide/ metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea. Clin. Ther. 25: 890-903 (2003) https://doi.org/10.1016/S0149-2918(03)80112-1
  5. Takahashi N, Kawada T, Goto T, Yamamoto T, Taimatsu A, Matsui N, Kimura K, Saito M, Hosokawa M, Miyashita K, Fushiki T. Dual action of isoprenols from herbal medicines on both PPARgamma and PPARalpha in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett. 514: 315-322 (2002) https://doi.org/10.1016/S0014-5793(02)02390-6
  6. Kamei R, Kadokura M, Kitagawa Y, Hazeki O, Oikawa S. 2'-benzyloxychalcone derivatives stimulate glucose uptake in 3T3-L1 adipocytes. Life Sci. 73: 2091-2099 (2003) https://doi.org/10.1016/S0024-3205(03)00563-0
  7. Herrmann BL, Schatz H, Pfeiffer A. Continuous blood glucose monitoring: the acute effect of acarbose on blood glucose variations. Med. Klin. 93: 651-655 (1998) https://doi.org/10.1007/BF03044876
  8. Oudjeriouat N, Moreau Y, Santimone M, Svensson B, Marchis- Mouren G, Desseaux V. On the mechanism of alpha-amylase. Eur. J. Biochem. 270: 3871-3879 (2003) https://doi.org/10.1046/j.1432-1033.2003.03733.x
  9. Hae J. DongEuBoGam. Namsandang, Seoul, Korea (1990)
  10. Tosi F, Muggeo M, Brun E, Spiazzi G, Perobelli L, Zanolin E, Gori M, Coppini A, Moghetti P. Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: a randomized, double-blind, comparative study. Metabolism 52: 862-867 (2003) https://doi.org/10.1016/S0026-0495(03)00101-X
  11. Scheen AJ. Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials. Diabetes Metab. 24: 311-320 (1998)
  12. Clissold SP, Edwards C. Acarbose: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 35: 214-243 (1988)
  13. Carrascosa JM, Molero JC, Fermin Y, Martinez C, Andres A, Satrustegui J. Effects of chronic treatment with acarbose on glucose and lipid metabolism in obese diabetic Wistar rats. Diabetes Obes. Metab. 3: 240-248 (2001) https://doi.org/10.1046/j.1463-1326.2001.00102.x
  14. Ishida H, Takamatsu M, Tsuji K, Kosuge T. Studies on active substances in herbs used for oketsu ("stagnant blood") in Chinese medicine. V. On the anticoagulative principle in moutan cortex. Chem. Pharm. Bull. (Tokyo) 35: 846-848 (1987) https://doi.org/10.1248/cpb.35.846
  15. Hirai A, Terano T, Hamazaki T, Sajiki J, Saito H, Tahara K, Tamura Y, Kumagai A. Studies on the mechanism of antiaggregatory effect of Moutan Cortex. Thromb. Res. 31: 29-40 (1983) https://doi.org/10.1016/0049-3848(83)90005-1
  16. Coniff R, Krol A. Acarbose: a review of US clinical experience. Clin. Ther. 19: 16-26 (1997) https://doi.org/10.1016/S0149-2918(97)80069-0
  17. Hayakawa T, Kondo T, Okumura N, Nagai K, Shibata T, Kitagawa M. Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha2 glucosidase inhibition. Am. J. Gastroenterol. 84: 523-526 (1989)